Overview
Portfolio
More
日本ベンチャーキャピタル株式会社
NVCC focuses on early‑stage Japanese startups, investing from the founding phase through to IPO. It leverages a wide network of large corporations and experienced entrepreneurs to provide capital, strategic guidance, and...
Portfolio
46+
Employees
10+
Founded
1996
AUM
≈ $1.1B
Investment focus
Stages
Pre-Seed → Series A
Industries
Software OnlyArtificial IntelligenceBiotechnologyClean Technology
Geographic scope
Japan
Fund details
Funds
NVCC10号投資事業有限責任組合
Vintage 2024 • $81.9M
デジタルヘルスファンド大阪投資事業有限責任組合
Vintage 2023 • $20.5M
NVCC9号投資事業有限責任組合
Vintage 2020 • $85.5M
阪大ベンチャーNVCC1号投資事業有限責任組合
Vintage 2019 • $10.0M
京大ベンチャーNVCC2号投資事業有限責任組合
Vintage 2018 • $49.1M
fabbit・NVCCスタートアップファンド投資事業有限責任組合
Vintage 2018 • $2.9M
NVCC8号投資事業有限責任組合
Vintage 2017 • $64.6M
名古屋大学・東海地区大学広域ベンチャー1号投資事業有限責任組合
Vintage 2016 • $22.8M
けいはんな学研都市ATRベンチャーNVCC投資事業有限責任組合
Vintage 2015 • $42.8M
NVCC7号投資事業有限責任組合
Vintage 2014 • $47.3M
埼玉りそな6次産業化応援ファンド投資事業有限責任組合
Vintage 2013 • $4.6M
NVCCスタートアップファンド投資事業有限責任組合
Vintage 2013 • $1.8M
ひょうご新産業創造ファンド投資事業有限責任組合
Vintage 2011 • $9.1M
大阪バイオファンド投資事業有限責任組合
Vintage 2010 • $10.2M
同志社ベンチャー1号投資事業有限責任組合
Vintage 2008 • $5.0M
京大ベンチャーNVCC1号投資事業有限責任組合
Vintage 2007 • $41.0M
埼玉成長企業サポートファンド投資事業有限責任組合
Vintage 2007 • $18.2M
NVCC6号投資事業有限責任組合
Vintage 2006 • $125.6M
がんばれ中小企業・活き活き育成投資事業有限責任組合 (2009/08/14 無限責任組合員の地位の譲受)
Vintage 2005 • $9.1M
東京NVCC投資事業有限責任組合
Vintage 2005 • $14.1M
エヌ・ブイ・シー・シー五号投資事業有限責任組合
Vintage 2004 • $65.5M
阪大イノベーション一号投資事業有限責任組合
Vintage 2003 • $27.5M
新潟産業創造ファンド一号投資事業有限責任組合
Vintage 2003 • $8.6M
エヌ・ブイ・シー・シー四号投資事業有限責任組合
Vintage 2002 • $34.6M
エヌ・ブイ・シー・シー関西三号投資事業有限責任組合
Vintage 2001 • $29.1M
エヌ・ブイ・シー・シー三号投資事業有限責任組合
Vintage 2001 • $29.1M
NVCC2号投資事業組合
Vintage 1999 • $41.0M
NVCC関西2号投資事業組合
Vintage 1999 • $17.3M
NVCC関西1号投資事業組合
Vintage 1998 • $45.5M
NVCC1号投資事業組合
Vintage 1996 • $128.3M
Sources
日本ベンチャーキャピタル株式会社
NVCC focuses on early‑stage Japanese startups, investing from the founding phase through to IPO. It leverages a wide network of large corporations and experienced entrepreneurs to provide capital, strategic guidance, and operational support across diverse technology sectors. The firm aims to nurture innovative companies that can drive sustainable growth and contribute to Japan’s economic revitalization.
Portfolio
46+
Employees
10+
Founded
1996
AUM
≈ $1.1B
Funds
NVCC10号投資事業有限責任組合 · Vintage 2024 • $81.9M
デジタルヘルスファンド大阪投資事業有限責任組合 · Vintage 2023 • $20.5M
NVCC9号投資事業有限責任組合 · Vintage 2020 • $85.5M
阪大ベンチャーNVCC1号投資事業有限責任組合 · Vintage 2019 • $10.0M
京大ベンチャーNVCC2号投資事業有限責任組合 · Vintage 2018 • $49.1M
fabbit・NVCCスタートアップファンド投資事業有限責任組合 · Vintage 2018 • $2.9M
NVCC8号投資事業有限責任組合 · Vintage 2017 • $64.6M
名古屋大学・東海地区大学広域ベンチャー1号投資事業有限責任組合 · Vintage 2016 • $22.8M
けいはんな学研都市ATRベンチャーNVCC投資事業有限責任組合 · Vintage 2015 • $42.8M
NVCC7号投資事業有限責任組合 · Vintage 2014 • $47.3M
埼玉りそな6次産業化応援ファンド投資事業有限責任組合 · Vintage 2013 • $4.6M
NVCCスタートアップファンド投資事業有限責任組合 · Vintage 2013 • $1.8M
ひょうご新産業創造ファンド投資事業有限責任組合 · Vintage 2011 • $9.1M
大阪バイオファンド投資事業有限責任組合 · Vintage 2010 • $10.2M
同志社ベンチャー1号投資事業有限責任組合 · Vintage 2008 • $5.0M
京大ベンチャーNVCC1号投資事業有限責任組合 · Vintage 2007 • $41.0M
埼玉成長企業サポートファンド投資事業有限責任組合 · Vintage 2007 • $18.2M
NVCC6号投資事業有限責任組合 · Vintage 2006 • $125.6M
がんばれ中小企業・活き活き育成投資事業有限責任組合 (2009/08/14 無限責任組合員の地位の譲受) · Vintage 2005 • $9.1M
東京NVCC投資事業有限責任組合 · Vintage 2005 • $14.1M
エヌ・ブイ・シー・シー五号投資事業有限責任組合 · Vintage 2004 • $65.5M
阪大イノベーション一号投資事業有限責任組合 · Vintage 2003 • $27.5M
新潟産業創造ファンド一号投資事業有限責任組合 · Vintage 2003 • $8.6M
エヌ・ブイ・シー・シー四号投資事業有限責任組合 · Vintage 2002 • $34.6M
エヌ・ブイ・シー・シー関西三号投資事業有限責任組合 · Vintage 2001 • $29.1M
エヌ・ブイ・シー・シー三号投資事業有限責任組合 · Vintage 2001 • $29.1M
NVCC2号投資事業組合 · Vintage 1999 • $41.0M
NVCC関西2号投資事業組合 · Vintage 1999 • $17.3M
NVCC関西1号投資事業組合 · Vintage 1998 • $45.5M
NVCC1号投資事業組合 · Vintage 1996 • $128.3M
Stages
Pre-Seed → Series A
Industries
Software OnlyArtificial IntelligenceBiotechnologyClean TechnologyHealthcare Technology
Geographic scope
Japan
Sources
Showing 24 of 37 matched portfolio companies
This company provides a centralized dispensing service specifically for veterinary clinics, utilizing an animal hospital-exclusive medical division model. They manage complex prescription fulfillment, including specialized compounding and detailed patient instructions, to reduce administrative burden on veterinarians. The service streamlines operations for clinics while ensuring pet owners receive timely, accurate medications delivered directly to their homes.
The startup offers a habit-building application that employs gamification and a team-based accountability system, where users collaborate in groups of five to foster routine development. This approach enhances user engagement and promotes skill acquisition, ultimately improving individual well-being.
The startup develops an eye-tracking assessment tool that utilizes a machine learning diagnostic algorithm to evaluate cognitive function through a series of questions similar to the mini-mental state examination. This method provides healthcare professionals with a low-stress, objective, and quantitative evaluation of cognitive abilities based on eye movement analysis.
Ai Robotics provides SELL, an AI‑powered platform that integrates real‑time data from e‑commerce, advertising, logistics, and CRM systems to deliver predictive demand forecasts, automated marketing optimization, and inventory allocation for direct‑to‑consumer brands. The solution offers dashboards and workflow automation that improve conversion, increase customer lifetime value, and reduce operational waste without requiring deep data‑science expertise.
AOI Biosciences provides a certified laboratory service that detects β2‑GPI neo‑self antibodies, offering a specific biomarker for autoimmune‑related infertility and recurrent pregnancy loss. It also supplies bio‑information analytics and quantum‑inspired SQBM™ optimization to help pharmaceutical partners identify allosteric drug targets and develop antibody‑drug conjugates for autoimmune diseases.
A-Seeds is a biotech company developing regenerative medicines that leverage stem cell therapy and gene editing techniques to enhance tissue regeneration in cancer patients. The company aims to improve patient outcomes by minimizing the side effects associated with traditional cancer treatments.
Funding: $3.1M
Rough estimate of the amount of funding raised
Funding: $3.1M
Rough estimate of the amount of funding raised
Awarefy develops cognitive behavioral therapy (CBT) applications designed to enhance mental well-being by providing users with structured therapeutic exercises and real-time mood tracking. The platform addresses the growing need for accessible mental health resources, enabling individuals to manage anxiety and depression effectively.
Founded 2018
Axelspace provides end‑to‑end microsatellite services through its AxelLiner platform, handling satellite bus development, launch procurement, insurance, ground‑station integration, and post‑launch operations so customers can run space missions without in‑house expertise. It also operates the AxelGlobe 100 kg‑class constellation, delivering high‑frequency, sub‑meter optical Earth imagery via a cloud‑based API for applications such as agriculture, disaster response, media, and environmental monitoring.
Funding: $43.5M
Rough estimate of the amount of funding raised
Funding: $43.5M
Rough estimate of the amount of funding raised
Creatura generates and distributes carbon credits while promoting renewable energy adoption to help companies reduce greenhouse gas emissions. By leveraging expertise in carbon credit development and a global network, the startup supports businesses in achieving their decarbonization goals effectively.
Funding: $2.3M
Rough estimate of the amount of funding raised
Funding: $2.3M
Rough estimate of the amount of funding raised
CynosBio is a specialty pharma that develops autologous regenerative medicine products, using a patient’s own cells cultured on human amniotic membrane or collagen matrices. Its marketed eye treatment, Sakurashi®, restores corneal surface health from oral mucosal epithelial sheets, while its IK‑01 therapy aims to regenerate knee cartilage by implanting cultured autologous chondrocytes. Both products are fully developed, manufactured, and distributed in‑house, enabling streamlined production and regulatory control.
EneCoat Technologies develops perovskite solar cells that maintain high energy conversion efficiency even in low-light conditions, utilizing a flexible film substrate for lightweight and versatile applications. The company aims to provide reliable power generation solutions for various environments, addressing the limitations of traditional solar technologies.
Funding: $49.6M
Rough estimate of the amount of funding raised
Funding: $49.6M
Rough estimate of the amount of funding raised
Enerbank operates a digital reverse auction platform for electricity procurement, enabling businesses and municipalities to secure the lowest energy rates from over 35 participating power suppliers. The platform addresses the rising costs of electricity by facilitating access to renewable energy sources and supporting decarbonization efforts through efficient procurement strategies.
Funding: $5.6M
Rough estimate of the amount of funding raised
Funding: $5.6M
Rough estimate of the amount of funding raised
Neusignal Therapeutics develops small-molecule therapeutics targeting Alzheimer's disease and other central nervous system disorders, utilizing proprietary signaling network insights to create novel compounds. The company addresses the unmet medical need for effective treatments that improve cognitive function and quality of life for patients suffering from dementia and psychiatric illnesses.
The startup provides e-sports training services through cloud-based coaching and e-learning platforms, enabling users to access structured educational content in virtual environments. It facilitates member management, scheduling, and opponent matchmaking at e-sports gyms, enhancing the training experience for competitive gamers.
Founded 2011
The startup provides a telehealth platform that facilitates pediatric-specific online medical consultations, allowing parents to access licensed physicians for diagnosis and prescription services from home. This approach addresses the challenge of limited access to specialized pediatric care, ensuring timely medical attention for children without the need for in-person visits.
Hootfolio offers a no‑code Causal AI SaaS that automatically discovers causal relationships from uploaded CSV datasets and visualizes them as directed‑acyclic graphs. The platform provides quantitative edge weights and counterfactual simulation tools, enabling analysts and managers in marketing, product, HR, and policy to test intervention scenarios and estimate ROI without specialized statistical expertise.
iiba is a geospatial platform that aggregates location-based information on child-rearing services, allowing users to search for and evaluate childcare-related facilities and activities through a user-friendly map interface. The platform addresses the challenges faced by busy families by reducing the time spent searching for suitable child-friendly locations, while also fostering a community-driven evaluation economy.
Junten Bio develops cell therapies utilizing induced regulatory T cells to achieve immune tolerance in organ transplantation, specifically targeting liver and kidney transplants. Their approach aims to mitigate immune rejection, allowing patients to reduce reliance on immunosuppressive drugs post-transplant.
The startup offers a risk assessment platform that provides consulting services for know your customer (KYC) and anti-money laundering (AML) compliance. Utilizing AI, the platform aggregates domestic and international risk data, enabling businesses to access real-time information on antisocial forces in Japan through an API-enabled risk database and credit checks for IPOs.
Founded 2011
LPIXEL develops AI-based medical image analysis technology to enhance diagnostic accuracy for healthcare professionals. Their solutions streamline the interpretation of diverse medical images, reducing the time required for diagnosis and improving patient outcomes.
Movus provides a modular robotics and automation platform for industrial manufacturers, combining multi‑axis manipulators with integrated 3‑D vision, force‑torque and proximity sensors for precise pick‑and‑place and assembly. Its adaptive motion‑control engine and plug‑and‑play connectivity (OPC UA, EtherCAT, Modbus) enable real‑time trajectory adjustment and seamless integration with existing PLC, SCADA or MES systems, while a web dashboard offers remote monitoring and task programming.
The startup offers a wedding planning platform that aggregates data on venues, jewelry, and other marriage-related services from online sources, including feedback from recently married couples. This centralized resource enables prospective brides and grooms to efficiently access essential information needed for organizing their weddings.
Founded 2011
This company develops a global platform focused on maximizing value across various services. Their offerings include an aggregate appraisal service for luxury watches and bags, supported by concierge service. Additionally, they operate e-commerce platforms and provide CRM solutions with AI authentication technology for the secondary distribution industry.
PharmaBio is a contract development and manufacturing organization that provides GMP‑compliant facility design, construction, and end‑to‑end manufacturing for cell‑ and tissue‑based therapies. It also offers regulatory support and a range of GMP‑qualified testing services, enabling biotech and pharma companies to scale regenerative medicine products efficiently and compliantly.
Showing 9 of 9 unmatched portfolio companies